TickerGuard
Buy Day today: Neutral (53) Mixed market breadth · no major macro event
Design (Testphase)

Momentum & Trend

Near 52-Week High

222 Hits
August 3, 2026 last calculated

Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Market filter active: the list shows 100 hits from US

No more than 5% below the 52-week high with RS rating ≥ 70 — strength near the high.

Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) and names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.

🔔 Watch scanner

Terms in This Scanner Explained

(17)
52-Week High / Low
The highest or lowest price of the last 52 weeks (one trading year). "Within 10% of the 52-week high" means: the stock is trading near its yearly high - a sign of strength, since weakness looks different.
ADR (Average Daily Range)
The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
AI Classification
Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
Analysis (Full Company Analysis)
If the Analysis column shows "Read," there is an in-depth TickerGuard company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
Avg/Yr 3Y (Average Annual Return)
The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
Earnings Date
The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
EPS (Earnings per Share)
Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
Free Cash Flow (FCF)
Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
Funda Rating (Fundamental Rating A+ to F)
Our proprietary fundamental rating from 0 to 100 points with a school-grade rank from A+ to F. 50 points is the average across the universe, 100 the best possible score. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below — A/A+ are the fundamentally strongest stocks in the universe.
Market Capitalization (Mkt Cap)
The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run.
Net Margin
How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
Operating Cash Flow (OCF)
The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
Piotroski F-Score
A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
Relative Strength (RS Rating)
How much has a stock risen compared with every other stock? The RS Rating is a percentile from 1 to 99: RS 90 means the stock has outperformed 90% of all stocks (depending on the scanner, over 1 week, 1, 3, 6, or 12 months). Market leaders almost always carry high RS values - that is why relative strength is the core of many momentum strategies.
Sector & Industry
Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
Stage (Weinstein Stages 1-4)
Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
Stress RS (Strength on Stress Days)
A stress day is a day on which both the overall market and the stock's own sector fell at least 0.5%. Stress RS counts on how many of these days the stock still closed green (shown as "g/n" = green days out of n stress days) and turns that into a rating from 1 to 99. High values point to buyers stepping in even on weak days - often a sign of institutional accumulation.

Hit List

Filter

Rating (traffic light)

Stage

Funda Rating

Piotroski

Columns ▾

This scanner's columns

Extra columns

Tip: clicking a column header sorts the table by that column; a second click flips the direction.

Near 52-Week High
Symbol Earnings Avg/Y 3Y Stress RS Stage Funda Rating Piotroski MktCap Industry AI Rating Deep Dive Deep-Dive Report Sector Price YTD 6 Mo. 1 Year Off High Price Target RS EPS Rating ADR 10D ADR 30D Beta P/E P/E (f) P/S P/B P/FCF PEG EV/EBITDA EBIT Margin Gross Margin Net Margin ROE ROA Debt/Eq Equity Ratio Sales +/Y Growth Score Div. Yield Payout Ratio Altman Z Inst. % Short % Analysts
UCTT Ultra Clean Holdings Inc 07/27 +70 % 92 10/25 Stage 2 C 45 2 of 9 4.1 $ Semiconductor Equipment & Materials Uses AI Technology 83.30 $ +340.7 % +399.2 % +269.9 % −3.5 % +39.7 % 98 17 8.9 % 8.7 % 1.83 34.6 2.0 5.9 0.99 349.0 2.1 % 15.6 % -9.4 % -22.5 % 1.4 % 1.52 33.9 % -2.1 % 5 0.0 % 0.0 % 6.3 102.9 % 10.7 % 4.8 (4)
LQDA Liquidia Technologies Inc 08/11 +241 % 93 9/22 Stage 2 A 75 7 of 9 7.5 $ Drug Manufacturers - Specialty & Generic Neutral Healthcare 84.10 $ +114.7 % +109.9 % +350.0 % −1.7 % +0.9 % 98 42 6.2 % 6.4 % 0.55 502.7 21.2 26.0 70.0 181.4 138.3 46.3 % 91.8 % 7.7 % 28.2 % 9.0 % 1.70 27.0 % +1,031.2 % 6 0.0 % 0.0 % 2.9 70.2 % 17.2 % 4.3 (10)
ORKA Oruka Therapeutics, Inc. 08/10 +78 % 79 7/22 Stage 2 D 33 1 of 9 6.0 $ Biotechnology Healthcare 96.50 $ +175.2 % +188.0 % +610.2 % −4.8 % +53.5 % 98 42 7.5 % 6.8 % 0.0 12.0 0.0 0.0 % 0.0 % -27.3 % -18.9 % 0.00 96.5 % +1,105.3 % 2 0.0 % 0.0 % 34.0 89.1 % 22.3 % 4.9 (8)
DFTX Definium Therapeutics, Inc. 07/30 +332 % Stage 2 D 26 1 of 9 0.0 $ Biotechnology Neutral Healthcare 43.50 $ +170.2 % +246.6 % +378.8 % −4.7 % +24.7 % 98 50 14.0 % 8.8 % 2.21 0.0 21.7 0.0 0.0 % 0.0 % -94.7 % -35.7 % 69.5 % 0.0 % 0.0 % 1.4 65.6 % 9.8 %
AIP Arteris Inc 08/04 +177 % 61 6/25 Stage 2 C 48 3 of 9 1.4 $ Semiconductors Sells AI Technology 29.90 $ +165.9 % +197.1 % +203.0 % −3.8 % +27.8 % 98 42 7.1 % 7.5 % 1.92 0.0 18.4 501.5 -7.7 -38.0 % 88.8 % -44.9 % -1,369.6 % -17.9 % 2.11 1.8 % +22.3 % 6 0.0 % 0.0 % -3.7 61.1 % 7.3 % 4.5 (4)
SLS Sellas Life Sciences Group Inc 08/11 +148 % Stage 2 C 53 3 of 9 0.0 $ Biotechnology Uses AI Healthcare 10.00 $ +140.6 % +444.0 % +529.6 % −4.8 % -5.0 % 98 50 12.4 % 11.1 % 2.43 0.0 -1.7 0.0 % 0.0 % -43.6 % -25.5 % 94.1 % -100.0 % 1 0.0 % 0.0 % 16.0 27.6 % 32.4 % 1.0 (3)
ALOT AstroNova Inc +30 % 95 11/25 Stage 2 C 51 9 of 9 0.2 $ Computer Hardware Neutral Technology 29.00 $ +228.3 % +249.6 % +156.2 % −0.8 % -8.6 % 98 81 8.8 % 6.2 % 0.86 14.0 1.5 22.6 38.6 33.8 % -0.9 % -1.8 % 2.6 % -0.5 % 0.0 % 0.0 % 7.3 44.9 % 0.2 %
RVMD Revolution Medicines Inc 08/05 +188 % 38 4/22 Stage 2 D 41 1 of 9 39.0 $ Biotechnology Healthcare 187.50 $ +112.8 % +137.2 % +403.2 % −3.4 % +10.4 % 97 42 4.8 % 4.4 % 1.38 0.0 27.2 -9.7 0.0 % -151,691.8 % 0.0 % -76.7 % -37.5 % 0.29 66.6 % -100.0 % 2 0.0 % 0.0 % 1.4 95.7 % 7.0 % 4.7 (12)
KLIC Kulicke and Soffa Industries Inc 08/05 +47 % 60 6/25 Stage 2 B 64 6 of 9 4.7 $ Semiconductor Equipment & Materials Neutral Technology 89.20 $ +180.3 % +179.3 % +176.2 % −1.4 % +12.1 % 97 6 7.6 % 6.8 % 1.63 81.7 20.8 6.1 5.4 1,085.3 2.38 48.1 15.9 % 49.8 % 7.2 % 6.4 % 3.9 % 0.05 72.3 % -7.4 % 4 0.9 % 54.3 % 13.9 93.1 % 6.1 % 4.0 (5)
ACMR Acm Research Inc 08/05 +247 % 73 7/25 Stage 2 B 57 3 of 9 5.4 $ Semiconductor Equipment & Materials Neutral Technology 78.50 $ +151.3 % +196.5 % +158.5 % −4.1 % +30.1 % 97 24 10.7 % 10.4 % 1.90 57.4 48.8 5.6 3.4 27.4 15.6 % 44.2 % 9.5 % 7.6 % 3.0 % 0.21 51.6 % +15.2 % 6 0.0 % 0.0 % 9.7 74.2 % 7.3 % 4.3 (9)
MBX MBX Biosciences, Inc. 08/06 69 6/22 Stage 2 D 34 3 of 9 3.0 $ Biotechnology Neutral Healthcare 65.90 $ +47.1 % +67.7 % +397.6 % −4.1 % +22.0 % 97 42 8.5 % 7.7 % 0.0 7.2 0.0 0.0 % 0.0 % -25.7 % -17.7 % 0.00 96.7 % 2 0.0 % 0.0 % 37.2 111.5 % 17.0 % 4.6 (5)
FLEX Flex Ltd 07/23 +225 % 72 7/25 Stage 2 B 64 6 of 9 42.8 $ Electronic Components Technology 113.80 $ +151.3 % +151.1 % +128.1 % −3.3 % +41.0 % 96 63 7.5 % 6.7 % 1.63 44.4 24.6 1.5 7.4 51.8 0.94 21.7 5.7 % 9.5 % 3.3 % 17.3 % 4.4 % 1.14 23.3 % +8.1 % 5 0.0 % 0.0 % 5.6 101.2 % 2.3 % 4.5 (11)
MKSI MKS Instruments Inc 08/05 +98 % 87 9/25 Stage 2 B 69 6 of 9 21.7 $ Scientific & Technical Instruments Uses AI Technology 297.50 $ +144.0 % +155.0 % +214.2 % −2.7 % +38.1 % 96 78 6.7 % 6.4 % 1.93 58.9 10.4 5.3 6.8 54.2 1.32 26.3 16.1 % 46.7 % 8.0 % 12.7 % 4.3 % 17.45 32.2 % +9.6 % 4 0.3 % 14.0 % 4.7 104.9 % 8.7 % 4.5 (12)
AGX Argan Inc +629 % 85 10/29 Stage 2 A 78 5 of 9 8.6 $ Engineering & Construction Uses AI Industrials 570.40 $ +135.6 % +141.6 % +134.0 % −4.8 % +19.2 % 96 86 7.0 % 7.0 % 0.56 50.9 16.6 8.2 16.9 17.6 43.3 15.6 % 20.7 % 15.5 % 38.5 % 9.4 % 36.8 % +8.1 % 8 0.4 % 17.6 % 8.1 108.9 % 6.7 % 4.0 (2)
GTX Garrett Motion Inc 07/23 +124 % 64 8/31 Stage 2 B 60 8 of 9 5.8 $ Auto Parts Uses AI Consumer Cyclical 31.20 $ +94.9 % +102.6 % +142.7 % −0.6 % +17.0 % 96 80 3.6 % 4.0 % 0.79 18.3 17.1 1.6 0.0 15.4 10.7 14.1 % 20.8 % 9.5 % 0.0 % 14.1 % -1.88 -32.9 % +3.1 % 2 1.0 % 17.3 % 2.6 96.1 % 2.9 % 4.0 (1)
APGE Apogee Therapeutics, Inc. 08/10 68 6/22 Stage 2 D 35 4 of 9 10.1 $ Biotechnology Healthcare 134.10 $ +76.0 % +69.8 % +250.5 % −0.4 % -2.7 % 96 42 6.7 % 6.5 % 0.33 0.0 8.0 0.0 0.0 % 0.0 % -28.5 % -19.0 % 0.01 97.1 % 3 0.0 % 0.0 % 40.3 131.6 % 7.0 % 5.0 (9)
TWST Twist Bioscience Corp 08/03 +131 % 54 5/22 Stage 2 D 43 4 of 9 5.7 $ Diagnostics & Research Threatened Healthcare 91.60 $ +168.0 % +192.9 % +172.7 % −1.8 % +1.0 % 96 42 7.7 % 7.8 % 2.12 0.0 13.9 12.9 -35.3 -34.9 % 52.1 % -19.9 % -18.2 % -12.9 % 0.21 67.3 % +20.3 % 5 0.0 % 0.0 % -0.1 123.8 % 29.1 % 4.2 (12)
TVTX Travere Therapeutics Inc 08/05 +82 % 68 6/22 Stage 2 B 64 5 of 9 5.1 $ Biotechnology Uses AI Healthcare 55.90 $ +46.4 % +44.7 % +261.8 % −1.8 % +5.8 % 96 42 3.6 % 4.6 % 1.11 76.3 9.5 51.5 292.4 136.5 -29.0 % 56.0 % -4.0 % -69.4 % -6.5 % 3.35 17.8 % +110.5 % 6 0.0 % 0.0 % -2.7 113.4 % 16.9 % 4.6 (15)
DWSN Dawson Geophysical Company 08/11 +12 % 57 2/10 Stage 2 B 65 5 of 9 0.1 $ Oil & Gas Equipment & Services Energy 4.70 $ +192.9 % +232.9 % +221.4 % −2.0 % -17.5 % 96 96 9.5 % 10.2 % -0.07 3.8 1.5 41.4 12.17 16.8 22.7 % 4.9 % 22.7 % 7.6 % +2.0 % 0.0 % 0.0 % -2.2 86.1 % 1.2 %
ONTO Onto Innovation Inc 08/06 +67 % 78 8/25 Stage 2 C 47 2 of 9 14.2 $ Semiconductor Equipment & Materials Technology 258.60 $ +100.1 % +117.1 % +172.9 % −2.5 % +42.9 % 95 15 8.1 % 7.3 % 1.55 113.7 36.1 13.7 5.7 59.3 1.20 61.5 16.8 % 54.2 % 10.3 % 5.3 % 5.4 % 89.0 % +1.8 % 5 0.0 % 0.0 % 16.2 100.4 % 6.8 % 4.1 (9)
SNEX Stonex Group Inc 08/04 +151 % 68 6/22 Stage 2 B 57 6 of 9 9.2 $ Capital Markets Neutral Financial Services 76.60 $ +117.5 % +77.2 % +77.2 % −3.3 % +46.2 % 95 87 6.0 % 4.9 % 0.66 20.3 9.8 0.1 3.3 1.2 11.5 0.5 % 1.6 % 0.3 % 20.2 % 1.1 % 7.16 5.0 % +32.5 % 2 0.0 % 0.0 % 5.5 85.9 % 7.1 % 5.0 (2)
MYRG MYR Group Inc 07/29 +84 % 76 9/29 Stage 2 B 68 9 of 9 5.4 $ Engineering & Construction Neutral Industrials 333.20 $ +114.2 % +120.8 % +72.2 % −0.9 % +30.0 % 95 86 5.2 % 5.4 % 1.31 36.1 28.0 1.3 7.2 27.7 3.41 17.3 6.4 % 12.5 % 4.1 % 22.7 % 8.5 % 0.11 42.0 % +8.8 % 5 0.0 % 0.0 % 6.9 104.4 % 6.1 % 4.6 (5)
MTRN Materion Corporation 08/05 +50 % 37 4/23 Stage 2 B 57 5 of 9 4.6 $ Other Industrial Metals & Mining Neutral Basic Materials 210.80 $ +113.8 % +126.6 % +101.0 % −1.5 % +19.9 % 95 57 5.2 % 4.9 % 1.03 58.8 32.6 2.4 4.7 685.7 1.28 26.8 5.7 % 16.4 % 4.0 % 8.3 % 4.0 % 0.83 51.0 % +6.1 % 3 0.3 % 13.5 % 8.4 97.2 % 4.4 % 4.0 (3)
SPHR Sphere Entertainment Co. 08/06 +158 % Stage 2 C 48 9 of 9 0.0 $ Entertainment Uses AI Communication Services 143.30 $ +66.4 % +83.4 % +232.8 % −0.4 % +5.6 % 95 50 4.7 % 4.8 % 1.60 58.5 28.4 2.8 11.6 2.7 % 55.1 % 8.6 % 5.5 % -1.0 % 0.42 53.2 % +0.0 % 5 0.0 % 0.0 % 4.9 130.0 % 37.2 % 1.5 (10)
TXG 10X Genomics Inc 08/06 -14 % 39 4/22 Stage 2 C 53 6 of 9 6.2 $ Health Information Services Uses AI Healthcare 47.30 $ +95.4 % +122.6 % +251.5 % −3.1 % -12.2 % 95 42 8.2 % 7.9 % 2.04 769.2 9.7 7.6 50.8 147.9 -11.3 % 69.7 % -3.6 % -3.0 % -4.5 % 0.10 80.2 % +5.3 % 4 0.0 % 0.0 % 6.5 113.8 % 19.0 % 3.8 (16)
CLOV Clover Health Investments Corp 08/04 +157 % 56 5/22 Stage 2 C 49 6 of 9 2.2 $ Healthcare Plans Uses AI Healthcare 4.20 $ +115.3 % +109.9 % +44.3 % −2.6 % +9.1 % 95 42 5.8 % 6.8 % 2.42 82.0 1.0 40.7 -0.6 3.7 % 18.4 % -2.6 % -16.9 % -5.6 % 48.7 % +40.3 % 5 0.0 % 0.0 % -5.8 30.0 % 6.9 % 4.0 (4)
ELVN Enliven Therapeutics Inc. 08/12 +44 % 69 6/22 Stage 2 D 29 4 of 9 3.7 $ Biotechnology Healthcare 54.80 $ +215.6 % +203.9 % +191.4 % −2.8 % +22.1 % 95 42 6.6 % 6.9 % 0.26 0.0 8.8 -6.3 0.0 % 0.0 % -26.6 % -18.9 % 0.00 97.5 % 2 0.0 % 0.0 % 47.0 89.7 % 17.7 % 4.9 (8)
AXGN Axogen Inc 08/04 +132 % 40 4/22 Stage 2 C 52 4 of 9 2.3 $ Medical Devices Healthcare 42.20 $ +36.5 % +37.0 % +222.5 % −3.3 % +26.1 % 95 42 5.2 % 4.9 % 1.09 5,000.0 9.0 9.2 271.9 99.04 4,083.5 -4.6 % 74.6 % -13.4 % -18.0 % -3.2 % 0.08 84.6 % +20.2 % 4 0.0 % 0.0 % 8.5 94.7 % 11.9 % 4.7 (7)
VSTS Vestis Corporation 08/04 76 9/29 Stage 2 C 45 8 of 9 1.9 $ Rental & Leasing Services Industrials 14.50 $ +97.9 % +120.0 % +138.6 % −2.0 % -28.3 % 95 3 3.9 % 4.3 % 1.15 0.0 0.7 19.5 15.3 4.2 % 26.1 % -0.6 % -2.0 % 2.2 % 30.2 % -2.5 % 4 0.0 % 0.0 % 4.9 101.7 % 8.9 % 3.3 (9)
NVCT Nuvectis Pharma Inc 08/04 +1 % 82 7/22 Stage 2 E 24 1 of 9 0.7 $ Biotechnology Healthcare 21.50 $ +132.5 % +270.0 % +209.2 % −0.2 % +47.9 % 95 42 16.4 % 9.8 % -0.25 0.0 -7.4 0.0 % -154.4 % -63.6 % -100.0 % 3 0.0 % 0.0 % -7.1 18.2 % 7.3 % 4.3 (6)
BTSG BrightSpring Health Services, Inc. 08/07 88 8/22 Stage 2 B 73 8 of 9 11.8 $ Health Information Services Uses AI Healthcare 59.70 $ +78.5 % +82.8 % +189.2 % −0.2 % +31.5 % 94 94 3.0 % 3.3 % 1.80 76.7 32.8 0.8 5.9 29.3 22.3 3.4 % 12.4 % 2.6 % 9.2 % 4.9 % -4.87 31.9 % +14.6 % 5 0.0 % 0.0 % 5.5 101.5 % 7.9 % 4.7 (12)
BHE Benchmark Electronics Inc 07/29 +95 % 87 9/25 Stage 2 B 61 8 of 9 2.9 $ Electronic Components Neutral Technology 79.80 $ +113.2 % +113.5 % +110.0 % −1.3 % +7.8 % 94 92 5.0 % 4.8 % 1.26 80.6 14.1 1.0 2.6 23.1 1.33 19.2 3.8 % 10.3 % 1.9 % 3.1 % 3.1 % 0.28 52.3 % +0.1 % 4 0.9 % 27.1 % 8.1 107.4 % 5.0 % 4.0 (3)
NESR National Energy Services Reunited Corp. 08/19 +252 % 56 2/10 Stage 2 B 64 7 of 9 2.7 $ Oil & Gas Equipment & Services Neutral Energy 27.00 $ +60.1 % +89.1 % +304.2 % −2.6 % +22.2 % 94 87 5.7 % 5.1 % 0.32 43.3 0.0 1.9 2.7 21.7 11.8 8.9 % 12.5 % 4.5 % 6.7 % 3.8 % 0.31 51.7 % +1.7 % 7 0.0 % 0.0 % 5.0 85.2 % 6.2 % 4.3 (3)
URGN UroGen Pharma Ltd 08/06 +18 % 69 6/22 Stage 2 B 57 3 of 9 1.8 $ Biotechnology Uses AI Healthcare 38.20 $ +50.1 % +51.8 % +100.6 % −4.7 % +17.1 % 94 42 5.1 % 5.4 % 1.58 0.0 13.1 -2.6 -39.8 % 89.9 % -94.8 % -1,481.3 % -27.0 % -49.0 % +21.5 % 4 0.0 % 0.0 % -8.0 100.6 % 11.9 % 4.4 (8)
MOV Movado Group Inc +25 % Stage 2 B 64 8 of 9 0.0 $ Luxury Goods Consumer Cyclical 38.20 $ +92.4 % +95.2 % +161.4 % −3.9 % +24.7 % 94 50 3.2 % 4.3 % 0.98 28.5 24.1 1.8 0.84 13.5 54.8 % 4.7 % 6.5 % 3.2 % 0.15 +2.7 % 5 4.3 % 92.4 % 11.5 91.4 % 5.3 %
MEI Methode Electronics Inc -18 % 62 6/25 Stage 2 D 35 3 of 9 0.5 $ Electronic Components Uses AI Technology 14.00 $ +104.6 % +185.0 % +118.5 % −2.3 % +38.1 % 94 2 13.1 % 9.7 % 1.47 10.2 0.5 0.8 12.0 0.78 9.9 19.9 % -3.5 % -9.3 % 0.7 % 0.52 -2.8 % 4 1.4 % 36.4 % 7.2 93.1 % 7.8 % 3.7 (3)
ACRS Aclaris Therapeutics Inc 08/06 -17 % 41 4/22 Stage 2 D 31 5 of 9 0.7 $ Biotechnology Healthcare 5.20 $ +63.5 % +65.1 % +239.9 % −4.7 % +92.3 % 94 42 5.9 % 5.5 % 0.77 0.0 85.6 0.3 -668.2 % 0.0 % -48.4 % -24.7 % -58.2 % 3 0.0 % 0.0 % -9.9 79.7 % 10.9 % 4.3 (6)
MEC Mayville Engineering Co Inc 08/04 +51 % 49 6/29 Stage 2 D 42 3 of 9 0.7 $ Metal Fabrication Industrials 25.70 $ +82.5 % +96.1 % +53.1 % −3.3 % +42.0 % 94 1 5.2 % 6.5 % 1.22 22.1 1.2 3.0 44.6 30.3 10.7 % -2.9 % -6.8 % -0.7 % 0.10 -6.0 % 5 0.0 % 0.0 % 4.6 60.8 % 6.8 % 4.3 (3)
RCUS Arcus Biosciences Inc 08/05 +16 % 40 4/22 Stage 2 D 34 0 of 9 3.5 $ Biotechnology Neutral Healthcare 28.20 $ +18.3 % +34.4 % +208.8 % −3.8 % +30.6 % 93 42 6.2 % 6.0 % 0.80 0.0 15.0 6.9 4.0 -788.2 % -121.6 % -156.4 % -70.0 % -23.1 % 0.22 52.6 % -4.3 % 4 0.0 % 0.0 % 1.0 72.4 % 16.4 % 4.5 (13)
CRS Carpenter Technology Corporation 07/30 +349 % 76 9/29 Stage 2 B 69 8 of 9 25.8 $ Metal Fabrication Neutral Industrials 519.70 $ +83.8 % +81.7 % +108.9 % −1.0 % +15.3 % 93 77 3.8 % 4.1 % 1.22 53.9 23.4 8.5 12.5 63.4 1.59 31.1 22.8 % 30.6 % 17.0 % 24.9 % 12.0 % 0.38 56.2 % +4.3 % 6 0.2 % 7.4 % 10.1 97.9 % 3.9 % 4.7 (9)
BELFB Bel Fuse B Inc 07/23 +142 % Stage 2 B 61 5 of 9 0.0 $ Electronic Components Neutral Technology 272.00 $ +70.3 % +79.3 % +109.4 % −0.4 % +2.3 % 93 50 5.4 % 5.5 % 1.38 75.3 33.1 10.1 2.21 30.1 13.5 % 39.2 % 7.8 % 14.2 % 7.3 % 0.52 46.1 % +26.3 % 3 0.1 % 3.9 % 8.4 90.5 % 5.9 % 1.0 (5)
TRVI Trevi Therapeutics Inc 08/06 +178 % 55 5/22 Stage 2 D 27 3 of 9 2.6 $ Biotechnology Healthcare 18.30 $ +38.8 % +43.6 % +146.5 % −0.9 % +43.1 % 93 42 6.1 % 5.0 % 1.00 0.0 -4.9 0.0 % 0.0 % -33.6 % -23.0 % 95.8 % 2 0.0 % 0.0 % 25.7 98.3 % 9.9 % 4.9 (8)
ALNT Allient Inc. 08/05 +50 % Stage 2 B 60 7 of 9 0.0 $ Electronic Components Neutral Technology 87.50 $ +78.9 % +77.1 % +117.5 % −2.3 % -27.8 % 93 50 6.4 % 6.4 % 1.59 68.8 34.1 5.5 23.8 7.3 % 32.9 % 4.3 % 8.2 % 5.1 % 0.65 53.0 % +4.6 % 6 0.2 % 5.9 % 8.4 78.8 % 5.5 % 1.3 (3)
PGEN Precigen Inc 08/11 +125 % 39 4/22 Stage 2 C 54 4 of 9 2.2 $ Biotechnology Neutral Healthcare 6.30 $ +28.2 % +41.3 % +266.7 % −2.8 % +98.4 % 93 42 6.5 % 6.9 % 1.01 312.5 70.9 117.8 -3.3 -25.8 % -35.4 % 0.0 % -1,145.4 % -42.1 % 4.86 14.6 % +146.7 % 2 0.0 % 0.0 % -57.6 71.1 % 21.2 % 3.8 (4)
CGEM Cullinan Oncology LLC 08/06 +14 % 55 5/22 Stage 2 C 47 1 of 9 1.0 $ Biotechnology Healthcare 16.50 $ +71.5 % +79.5 % +112.4 % −1.5 % +91.7 % 93 42 8.3 % 8.2 % -0.01 6.7 -1.5 0.0 % -48.2 % -30.6 % -100.0 % 3 0.0 % 0.0 % 10.2 107.8 % 23.8 % 4.9 (9)
CTOS Custom Truck One Source Inc 07/29 +23 % 59 7/29 Stage 2 B 59 7 of 9 2.3 $ Rental & Leasing Services Industrials 10.20 $ +95.3 % +99.5 % +64.0 % −2.1 % +12.7 % 93 21 4.8 % 4.3 % 1.35 67.6 1.2 2.9 11.5 21.7 % -0.9 % -2.2 % 2.8 % 3.09 +7.9 % 3 0.0 % 0.0 % 3.8 97.0 % 5.4 % 4.0 (6)
WEST Westrock Coffee Company 08/06 -6 % Stage 2 D 41 3 of 9 0.0 $ Packaged Foods Consumer Defensive 8.10 $ +123.1 % +98.3 % +22.1 % −2.4 % -8.8 % 93 50 7.4 % 6.7 % 0.90 0.0 44.0 13.0 % -5.6 % -24.0 % -0.9 % +39.8 % 3 0.0 % 0.0 % 1.8 49.5 % 13.2 %
BELFA Bel Fuse A Inc 07/23 +120 % 73 7/25 Stage 2 B 69 6 of 9 2.8 $ Electronic Components Technology 223.10 $ +66.6 % +73.7 % +95.1 % −3.0 % +41.6 % 93 18 5.9 % 5.9 % 1.38 27.8 4.0 38.1 1.85 26.7 39.5 % 7.2 % 14.2 % 6.9 % +26.3 % 4 0.1 % 3.0 % 8.4 56.2 % 8.6 % 5.0 (2)
CCCC C4 Therapeutics Inc 08/06 -23 % 57 5/22 Stage 2 D 37 4 of 9 0.4 $ Biotechnology Healthcare 3.50 $ +120.9 % +109.1 % +69.8 % −4.3 % +281.0 % 93 42 7.7 % 9.3 % 2.91 0.0 11.4 1.7 -0.4 78.3 % -297.8 % -48.4 % -19.9 % 0.25 +1.0 % 0.0 % 0.0 % 0.5 85.1 % 21.7 % 4.0 (8)
ATI ATI Inc. 07/30 +136 % 90 11/29 Stage 2 B 64 8 of 9 26.1 $ Metal Fabrication Industrials 187.40 $ +73.9 % +69.5 % +143.6 % −2.8 % +6.9 % 92 69 3.3 % 4.1 % 0.96 61.2 43.5 5.7 14.3 47.3 1.20 32.9 16.1 % 23.2 % 9.3 % 22.7 % 8.3 % 1.18 33.8 % +5.2 % 4 0.0 % 0.0 % 7.2 96.9 % 4.2 % 4.5 (11)
GH Guardant Health Inc 07/29 +89 % 78 7/22 Stage 2 B 55 6 of 9 21.5 $ Diagnostics & Research Sells AI Healthcare 162.00 $ +28.1 % +50.2 % +295.3 % −2.0 % +15.7 % 92 42 5.3 % 5.7 % 1.59 0.0 18.2 63.1 -5.4 -40.2 % 65.0 % -38.3 % -4,584.5 % -18.1 % -6.60 -9.5 % +32.9 % 3 0.0 % 0.0 % 0.1 106.0 % 9.0 % 4.7 (23)
ALGM Allegro Microsystems Inc 07/30 +12 % 72 7/25 Stage 2 B 67 5 of 9 8.6 $ Semiconductors Sells AI Technology 41.50 $ +110.5 % +146.3 % +32.1 % −2.5 % +31.0 % 92 15 9.2 % 8.1 % 1.90 43.7 9.1 7.5 97.5 78.0 10.4 % 47.4 % 1.5 % -1.6 % 3.0 % 0.30 67.5 % +22.8 % 5 0.0 % 0.0 % 7.0 76.2 % 12.8 % 4.6 (11)
IESC IES Holdings Inc 08/07 +416 % 59 7/29 Stage 2 A 78 6 of 9 15.8 $ Engineering & Construction Neutral Industrials 744.50 $ +82.6 % +77.9 % +110.9 % −4.7 % -6.0 % 92 79 7.0 % 6.3 % 1.78 37.1 208.3 4.0 12.9 44.8 22.7 11.5 % 26.3 % 11.4 % 42.1 % 16.5 % 0.11 53.8 % +16.9 % 7 0.0 % 0.0 % 9.3 96.9 % 8.7 %
KN Knowles Corporation 07/23 +45 % 46 5/25 Stage 2 B 60 7 of 9 3.3 $ Electronic Components Technology 36.60 $ +87.1 % +85.2 % +80.2 % −5.0 % +19.5 % 92 61 4.9 % 4.6 % 1.59 51.5 15.2 5.4 4.0 45.7 0.43 24.1 11.8 % 45.3 % 10.6 % 8.2 % 5.5 % 0.19 74.0 % +7.2 % 5 0.0 % 0.0 % 6.3 103.9 % 8.2 % 4.3 (4)
MRX Marex Group plc Ordinary Shares 08/12 79 7/22 Stage 2 B 61 4 of 9 4.6 $ Capital Markets Financial Services 64.90 $ +74.6 % +49.3 % +70.9 % −4.8 % +11.5 % 92 79 4.9 % 4.7 % -0.09 14.7 8.8 0.8 3.5 6.1 13.1 % 68.9 % 10.6 % 29.1 % 1.1 % 3.7 % +25.4 % 8 1.0 % 17.1 % 4.2 75.2 % 5.1 % 4.3 (8)
ROG Rogers Corporation 07/30 +0 % 46 5/25 Stage 2 B 55 9 of 9 2.3 $ Electronic Components Technology 123.50 $ +73.8 % +75.1 % +88.3 % −1.1 % +40.4 % 92 24 5.1 % 5.0 % 0.49 6.5 2.8 1.8 23.0 0.77 17.6 8.3 % 32.4 % 3.8 % -4.5 % 3.2 % 0.02 83.6 % -2.3 % 3 0.0 % 0.0 % 13.2 102.2 % 4.1 % 4.3 (3)
ETON Eton Pharmaceuticals Inc 08/06 +249 % 96 10/22 Stage 2 B 55 7 of 9 1.3 $ Drug Manufacturers - Specialty & Generic Healthcare 46.40 $ +98.0 % +116.2 % +227.8 % −2.4 % +18.0 % 92 26 4.8 % 5.7 % 0.86 52.6 14.7 42.5 82.9 206.8 59.7 % -1.7 % -5.4 % 4.8 % 0.40 +104.9 % 8 0.0 % 0.0 % 0.7 65.4 % 6.3 % 4.7 (3)
ULCC Frontier Group Holdings Inc 08/04 -7 % 49 6/29 Stage 2 D 41 3 of 9 1.5 $ Airlines Industrials 6.80 $ +53.9 % +55.0 % +54.1 % −4.1 % -0.3 % 92 52 7.3 % 7.6 % 2.57 13.9 0.4 6.5 100.0 0.5 % -9.3 % -92.4 % -5.3 % 23.64 -1.4 % 4 0.0 % 0.0 % 1.7 55.2 % 40.8 % 3.0 (12)
CADL Candel Therapeutics Inc 08/13 +23 % 70 6/22 Stage 2 D 36 3 of 9 0.7 $ Biotechnology Healthcare 10.00 $ +60.7 % +70.4 % +55.3 % −1.5 % +105.0 % 92 42 6.6 % 7.0 % -0.51 43.5 5.2 0.0 -74,432.3 % 0.0 % -51.2 % -23.6 % 0.01 -100.0 % 3 0.0 % 0.0 % 6.2 59.8 % 23.0 % 5.0 (3)
IMUX Immunic Inc 08/06 +0 % 70 6/22 Stage 2 D 28 5 of 9 0.2 $ Biotechnology Healthcare 14.00 $ +182.2 % +163.9 % +48.6 % −4.4 % +196.4 % 92 42 6.7 % 8.8 % 1.38 0.0 0.2 0.0 % -142.9 % -65.2 % -100.0 % 0.0 % 0.0 % -2.1 46.9 % 12.7 %
ROIV Roivant Sciences Ltd 08/10 +76 % 38 4/22 Stage 2 D 44 3 of 9 23.7 $ Biotechnology Uses AI Healthcare 33.90 $ +48.4 % +54.4 % +198.5 % −1.9 % +14.8 % 91 2 3.9 % 4.0 % 1.11 0.0 2,857.0 5.4 0.7 -14,675.1 % -8,159.0 % 0.0 % -7.6 % -14.4 % 0.02 79.0 % -71.6 % 5 0.0 % 0.0 % 19.2 75.9 % 6.7 % 4.5 (10)
ARW Arrow Electronics Inc 07/30 +22 % 72 7/25 Stage 2 B 66 7 of 9 11.5 $ Electronics & Computer Distribution Sells AI Technology 216.60 $ +104.6 % +91.0 % +86.7 % −3.5 % +2.5 % 91 90 3.3 % 3.6 % 1.20 14.6 5.0 0.3 1.5 30.6 0.95 10.5 4.2 % 11.3 % 2.2 % 11.3 % 2.5 % 0.53 18.8 % +10.5 % 2 0.0 % 0.0 % 5.5 108.6 % 3.3 % 2.7 (6)
KRYS Krystal Biotech Inc 08/03 +62 % 53 5/22 Stage 2 A 80 7 of 9 10.2 $ Biotechnology Uses AI Healthcare 341.10 $ +38.0 % +50.5 % +121.7 % −0.7 % +12.7 % 91 78 4.2 % 3.9 % 0.50 46.7 45.0 24.4 7.9 42.9 49.9 46.1 % 94.2 % 53.9 % 19.9 % 9.0 % 0.01 91.4 % +33.9 % 7 0.0 % 0.0 % 19.8 99.4 % 19.5 % 4.6 (11)
PLXS Plexus Corp 07/22 +70 % 46 5/25 Stage 2 B 65 8 of 9 6.7 $ Electronic Components Uses AI Technology 251.30 $ +96.3 % +86.9 % +97.1 % −3.3 % +21.7 % 91 70 4.1 % 4.2 % 0.88 36.8 26.2 1.6 4.5 88.7 2.09 22.1 5.3 % 10.0 % 4.0 % 13.2 % 4.3 % 0.17 44.3 % +1.8 % 5 0.0 % 0.0 % 8.4 104.4 % 4.6 % 3.8 (5)
ECG Everus Construction Group Inc 08/11 Stage 2 B 70 6 of 9 0.0 $ Engineering & Construction Neutral Industrials 125.40 $ +82.8 % +78.6 % +68.9 % −4.7 % +3.7 % 91 50 5.6 % 5.4 % 36.8 36.4 11.9 23.1 7.5 % 12.4 % 5.7 % 39.0 % 11.4 % 0.53 37.2 % +31.5 % 6 0.0 % 0.0 % 8.2 86.7 % 4.7 % 1.5 (4)
KGS Kodiak Gas Services, Inc. 08/05 98 5/10 Stage 2 B 56 7 of 9 5.8 $ Oil & Gas Equipment & Services Energy 58.70 $ +94.9 % +106.1 % +89.8 % −4.8 % +42.3 % 91 17 4.1 % 3.8 % 0.82 73.8 26.0 4.4 5.1 29.2 15.3 33.7 % 64.2 % 5.1 % 5.4 % 6.0 % 0.06 26.1 % +12.8 % 7 3.3 % 1.8 % 4.2 91.3 % 9.5 % 4.4 (11)
COCO Vita Coco Company Inc 07/29 +64 % Stage 2 B 72 6 of 9 0.0 $ Beverages - Non-Alcoholic Consumer Defensive 65.90 $ +56.1 % +35.8 % +87.0 % −3.8 % -9.0 % 91 50 4.8 % 4.2 % 0.76 58.8 28.8 13.1 36.6 18.7 % 37.4 % 12.6 % 26.3 % 13.9 % 0.04 72.1 % +18.2 % 6 0.0 % 0.0 % 13.5 96.2 % 9.9 % 1.5 (10)
HLIO Helios Technologies Inc 08/03 +15 % 37 5/29 Stage 2 B 67 9 of 9 2.6 $ Specialty Industrial Machinery Industrials 77.90 $ +67.8 % +61.8 % +113.7 % −2.3 % +13.6 % 91 89 4.0 % 3.8 % 1.26 11.7 3.0 23.9 1.03 17.8 13.1 % 32.9 % 7.0 % 6.7 % 4.4 % 61.9 % +4.1 % 3 0.6 % 18.0 % 7.8 101.8 % 2.9 % 4.4 (5)
DHC Diversified Healthcare Trust 08/03 +127 % 44 4/21 Stage 2 D 41 4 of 9 2.1 $ REIT - Healthcare Facilities Uses AI Real Estate 8.90 $ +89.0 % +97.1 % +174.0 % −0.5 % +11.0 % 91 9 4.3 % 4.0 % 2.27 16.6 1.4 1.3 1.89 50.9 -1.3 % 17.7 % -21.1 % -17.9 % -0.5 % 1.49 38.0 % +2.8 % 3 0.5 % 2.3 % 1.6 84.3 % 5.8 % 3.3 (3)
GHM Graham Corporation 08/04 +251 % Stage 2 C 54 1 of 9 0.0 $ Specialty Industrial Machinery Industrials 95.90 $ +70.9 % +69.7 % +67.8 % −1.0 % +6.4 % 91 50 6.2 % 6.7 % 1.01 58.8 3.26 59.6 1.3 % 23.6 % 5.1 % 9.6 % 3.4 % 43.4 % +16.9 % 6 0.0 % 0.0 % 5.4 80.2 % 4.6 % 1.2 (5)
GRC Gorman-Rupp Company 07/24 +78 % 49 6/29 Stage 2 B 64 8 of 9 2.2 $ Specialty Industrial Machinery Industrials 81.20 $ +82.1 % +82.1 % +100.0 % −0.6 % -0.7 % 91 76 3.5 % 3.4 % 1.28 35.6 30.4 3.1 5.0 20.9 2.34 18.3 15.4 % 31.8 % 8.9 % 14.5 % 7.6 % 0.69 49.4 % +3.4 % 5 0.9 % 30.5 % 7.9 67.0 % 2.5 % 5.0 (1)
PLPC Preformed Line Products Company 07/29 +47 % 67 8/29 Stage 2 B 59 5 of 9 1.8 $ Electrical Equipment & Parts Industrials 357.00 $ +85.8 % +87.8 % +132.1 % −0.6 % +4.2 % 91 27 5.3 % 5.3 % 0.89 7.8 2.5 53.1 20.7 7.8 % 31.4 % 5.8 % 7.5 % 6.2 % 71.6 % +12.7 % 4 0.2 % 9.4 % 11.7 68.3 % 11.5 %
LIND Lindblad Expeditions Holdings Inc 08/03 +50 % 43 6/31 Stage 2 B 66 8 of 9 2.0 $ Travel Services Consumer Cyclical 29.60 $ +78.7 % +94.4 % +147.5 % −1.1 % -4.7 % 91 94 5.8 % 5.4 % 2.23 243.9 2.4 165.4 23.5 24.5 7.5 % 46.0 % -3.1 % -1,946.9 % 3.8 % -3.50 -19.3 % +19.6 % 6 0.0 % 0.0 % 1.3 75.0 % 11.6 % 4.3 (3)
TWIN Twin Disc Incorporated 08/20 +34 % 76 9/29 Stage 2 B 74 8 of 9 0.3 $ Specialty Industrial Machinery Neutral Industrials 22.80 $ +33.5 % +38.1 % +166.9 % −1.2 % +31.6 % 91 98 5.8 % 6.1 % 0.64 12.8 7.5 0.9 1.8 470.0 3.16 14.2 28.2 % 7.3 % 16.1 % 2.4 % 0.36 +15.5 % 0.7 % 9.2 % 7.9 68.5 % 5.0 %
HUM Humana Inc 07/29 -6 % 98 11/22 Stage 2 B 57 7 of 9 43.8 $ Healthcare Plans Healthcare 363.90 $ +40.9 % +51.3 % +47.7 % −1.3 % +12.1 % 90 29 3.6 % 3.5 % 0.72 39.7 40.0 0.3 2.4 34.4 2.06 0.0 4.7 % 13.7 % 0.9 % 6.3 % 3.9 % 1.73 33.6 % +10.1 % 3 1.0 % 20.6 % 6.5 99.9 % 4.0 % 3.6 (26)
CNC Centene Corp 07/28 -2 % 98 11/22 Stage 2 B 56 9 of 9 30.7 $ Healthcare Plans Uses AI Healthcare 62.20 $ +53.4 % +61.8 % +138.7 % −2.7 % +13.6 % 90 64 3.6 % 3.6 % 1.08 18.1 0.2 1.4 3.8 1.20 3.9 5.1 % 11.4 % -2.8 % -26.0 % 2.5 % 1.55 26.4 % +19.4 % 3 0.0 % 0.0 % 4.0 100.6 % 3.1 % 3.9 (19)
LFUS Littelfuse Inc 07/29 +26 % 45 5/25 Stage 2 B 62 7 of 9 11.7 $ Electronic Components Technology 442.10 $ +85.3 % +73.0 % +73.5 % −4.7 % +10.6 % 90 81 4.6 % 4.5 % 1.49 27.5 4.7 4.2 30.2 2.30 45.9 17.3 % 39.3 % -0.3 % -1.6 % 6.7 % 0.07 65.2 % +8.9 % 2 0.7 % 23.2 % 8.3 105.2 % 5.8 % 3.7 (6)
ESI Element Solutions Inc 07/29 +54 % Stage 2 D 40 2 of 9 0.0 $ Specialty Chemicals Basic Materials 36.70 $ +84.3 % +80.8 % +57.3 % −3.1 % +0.6 % 90 50 5.3 % 4.6 % 1.24 71.5 24.9 4.1 28.0 14.0 % 40.8 % 5.3 % 5.6 % 4.5 % 0.79 47.7 % +3.8 % 5 0.7 % 20.5 % 5.0 105.6 % 8.7 % 1.1 (11)
ALKS Alkermes Plc 08/04 +15 % 68 6/22 Stage 2 C 53 1 of 9 8.2 $ Drug Manufacturers - Specialty & Generic Healthcare 49.00 $ +71.8 % +84.2 % +84.9 % −1.6 % +14.3 % 90 9 4.8 % 4.2 % 0.29 56.8 133.3 4.9 4.9 36.8 1.96 41.9 -0.2 % 87.2 % 4.0 % 9.4 % 4.2 % 0.90 41.1 % -5.3 % 5 0.0 % 0.0 % 4.9 110.5 % 12.5 % 4.1 (15)
INDV Indivior Pharmaceuticals, Inc. 07/30 +25 % 68 6/22 Stage 2 B 61 4 of 9 4.5 $ Drug Manufacturers - Specialty & Generic Neutral Healthcare 40.00 $ +11.4 % +14.1 % +98.1 % −1.9 % +27.1 % 90 83 3.6 % 3.6 % 1.15 20.8 13.0 3.5 140.7 14.3 46.1 % 85.0 % 19.5 % 12.2 % 22.7 % -3.49 -12.0 % +4.3 % 4 0.0 % 0.0 % 3.6 107.5 % 11.3 % 4.7 (7)
ATEN A10 Networks, Inc. 08/04 +48 % 92 10/25 Stage 2 B 63 7 of 9 2.1 $ Software - Infrastructure Technology 29.60 $ +92.3 % +102.9 % +62.5 % −1.3 % +20.3 % 90 71 4.1 % 4.3 % 1.14 41.5 7.1 41.6 14.76 24.8 17.3 % 79.3 % 14.9 % 21.4 % 5.2 % 34.8 % +11.0 % 5 0.8 % 32.9 % 7.7 103.9 % 13.5 % 4.2 (6)
CALY Callaway Golf Company 08/05 +9 % Stage 2 B 60 6 of 9 0.0 $ Leisure Consumer Cyclical 18.50 $ +53.6 % +61.8 % +113.2 % −0.8 % +1.7 % 90 50 4.1 % 4.1 % 0.93 73.6 40.2 1.6 0.72 17.2 20.1 % 43.0 % -15.0 % 2.2 % 1.9 % 0.32 66.8 % -51.4 % 5 9.7 % 92.1 % 6.8 81.7 % 5.0 %
ATLC Atlanticus Holdings Corporation 08/06 +51 % 41 4/22 Stage 2 B 71 6 of 9 1.6 $ Credit Services Uses AI Financial Services 105.50 $ +51.4 % +49.6 % +112.6 % −2.8 % +19.4 % 90 77 6.3 % 6.0 % 2.12 7.9 1.3 2.0 0.0 72.4 % 21.4 % 21.4 % 2.5 % +53.3 % 7 0.0 % 0.0 % 4.5 25.0 % 25.8 % 4.3 (7)
FSTR LB Foster Company 08/10 +74 % 37 5/29 Stage 2 C 52 6 of 9 0.4 $ Railroads Industrials 41.10 $ +63.0 % +59.5 % +75.0 % −2.6 % -2.7 % 90 4 3.9 % 4.2 % 1.14 40.0 29.4 0.8 2.5 12.3 0.82 13.4 21.5 % 2.0 % 6.4 % 5.4 % 0.48 +1.7 % 0.0 % 0.0 % 8.4 72.3 % 4.5 % 3.0 (1)
MG Mistras Group Inc 08/05 +56 % 60 7/29 Stage 2 C 45 8 of 9 0.5 $ Security & Protection Services Industrials 15.20 $ +50.8 % +38.6 % +91.6 % −4.4 % +38.2 % 90 21 3.7 % 3.8 % 0.89 14.6 0.7 607.5 0.91 9.0 31.6 % 3.1 % 10.4 % 6.3 % -0.8 % 5 0.0 % 0.0 % 5.6 62.5 % 9.9 % 5.0 (1)
PKOH Park Ohio Holdings Corp 08/05 +40 % 67 8/29 Stage 2 D 42 5 of 9 0.6 $ Specialty Industrial Machinery Industrials 39.90 $ +75.6 % +82.0 % +150.0 % −0.4 % +9.0 % 90 30 4.1 % 4.4 % 1.17 23.3 13.1 0.4 1.5 1,427.5 1.09 11.6 17.1 % 1.5 % 5.7 % 4.0 % 1.82 -3.5 % 3 1.3 % 25.6 % 7.0 55.2 % 2.0 % 3.0 (1)
GNRC Generac Holdings Inc 07/29 +38 % 59 7/29 Stage 2 B 63 9 of 9 12.5 $ Specialty Industrial Machinery Industrials 197.10 $ +101.3 % +101.6 % +1.2 % −0.4 % +45.5 % 89 82 5.7 % 5.7 % 1.90 58.1 22.9 2.9 4.1 37.8 0.81 20.8 11.1 % 39.5 % 5.8 % 7.4 % 4.7 % 1.11 47.8 % -2.0 % 3 0.0 % 0.0 % 7.8 94.0 % 3.3 % 4.0 (23)
NPO Enpro Industries 08/04 +66 % 66 8/29 Stage 2 B 57 7 of 9 6.6 $ Specialty Industrial Machinery Industrials 313.90 $ +72.0 % +66.3 % +48.6 % −2.6 % +14.4 % 89 60 4.3 % 3.9 % 1.51 152.7 34.2 5.7 4.2 38.4 2.28 36.1 15.9 % 43.1 % 3.7 % 2.9 % 4.3 % 0.40 59.3 % +9.0 % 4 0.4 % 20.6 % 7.1 102.1 % 2.7 % 5.0 (3)
AVT Avnet Inc 08/05 +35 % 60 6/25 Stage 2 B 55 5 of 9 7.3 $ Electronics & Computer Distribution Technology 88.80 $ +88.1 % +79.7 % +71.7 % −4.7 % +0.8 % 89 60 3.2 % 3.6 % 1.11 32.6 7.1 0.3 1.5 221.4 2.65 14.9 3.1 % 10.5 % 0.9 % 4.4 % 3.4 % 0.77 36.7 % -6.6 % 2 1.6 % 41.5 % 7.8 110.1 % 9.2 % 2.8 (5)
LGND Ligand Pharmaceuticals Incorporated 08/06 +94 % 54 5/22 Stage 2 B 58 5 of 9 5.4 $ Biotechnology Healthcare 287.50 $ +47.8 % +59.3 % +118.5 % −1.4 % +12.5 % 89 86 5.6 % 4.1 % 0.98 38.4 32.3 19.7 5.9 43.9 1.53 24.2 33.6 % 83.2 % 56.0 % 17.1 % 5.2 % 0.51 65.1 % +60.4 % 7 0.0 % 0.0 % 10.8 106.4 % 11.5 % 4.6 (7)
ASTH Astrana Health Inc 08/06 +13 % 70 6/22 Stage 2 B 62 5 of 9 1.8 $ Medical Care Facilities Uses AI Healthcare 35.60 $ +66.1 % +79.3 % +49.0 % −0.5 % +38.6 % 89 87 3.6 % 3.8 % 0.89 23.0 0.5 11.4 14.4 3.0 % 10.7 % 0.9 % 5.7 % 3.6 % 33.9 % +56.4 % 5 0.0 % 0.0 % 5.2 61.5 % 10.3 % 4.5 (12)
AMN AMN Healthcare Services Inc 08/06 -23 % 93 9/22 Stage 2 B 59 8 of 9 1.3 $ Medical Care Facilities Threatened Healthcare 33.60 $ +98.2 % +102.2 % +83.4 % −2.4 % -5.2 % 89 93 4.9 % 5.2 % 0.42 26.2 0.4 1.8 1.71 7.5 27.6 % -1.0 % -4.5 % 3.5 % -8.5 % 2 0.0 % 0.0 % 5.6 115.6 % 11.1 % 3.3 (9)
CARE Carter Bank and Trust 07/23 +38 % 69 6/22 Stage 2 B 62 7 of 9 0.8 $ Banks - Regional Neutral Financial Services 34.60 $ +65.1 % +68.4 % +99.7 % −1.1 % -8.0 % 89 96 2.7 % 2.8 % 0.51 13.7 2.4 2.4 0.0 100.0 % 44.9 % 23.9 % 2.7 % +6.2 % 6 1.2 % 12.5 % -1.9 59.2 % 8.6 % 4.7 (3)
CYTK Cytokinetics Inc 08/06 +8 % 68 6/22 Stage 2 D 39 3 of 9 10.4 $ Biotechnology Neutral Healthcare 77.10 $ +25.9 % +36.0 % +104.9 % −2.6 % +39.8 % 88 42 4.6 % 4.1 % 0.42 117.6 97.8 57.5 -15.8 -948.7 % -290.7 % 0.0 % -572.2 % -31.5 % -1.56 -64.9 % +376.6 % 3 0.0 % 0.0 % -7.3 118.8 % 19.4 % 4.3 (21)
CGON CG Oncology, Inc. Common stock 08/14 68 6/22 Stage 2 C 51 4 of 9 6.3 $ Biotechnology Healthcare 71.20 $ +58.3 % +83.7 % +166.7 % −3.5 % +27.4 % 88 42 6.2 % 5.5 % 0.22 0.0 1,240.6 5.8 0.0 -6,130.1 % -2,670.9 % 0.0 % -20.8 % -14.4 % 0.01 96.2 % +254.7 % 4 0.0 % 0.0 % 33.4 109.9 % 14.0 % 4.4 (10)
GEO Geo Group Inc 08/05 +109 % 97 14/29 Stage 2 B 70 9 of 9 4.1 $ Security & Protection Services Neutral Industrials 30.90 $ +85.9 % +78.2 % +19.2 % −3.5 % +9.2 % 88 86 3.8 % 3.8 % 0.78 16.2 26.7 1.5 2.8 1.91 8.7 12.7 % 25.5 % 10.0 % 19.3 % 5.5 % 1.11 39.3 % +8.6 % 2 0.0 % 0.0 % 5.6 95.2 % 11.1 % 5.0 (4)
DCO Ducommun Incorporated 08/06 +90 % 60 7/29 Stage 2 C 46 5 of 9 2.7 $ Aerospace & Defense Industrials 179.00 $ +70.6 % +88.2 % +96.8 % −1.5 % +1.1 % 88 96 4.5 % 4.1 % 1.03 39.4 3.3 4.2 3.34 232.6 7.5 % 27.0 % -3.4 % -4.2 % 4.6 % 0.51 56.5 % +4.9 % 1 0.0 % 0.0 % 8.1 95.8 % 4.9 % 4.6 (5)
PEB Pebblebrook Hotel Trust 07/29 +15 % 74 6/21 Stage 2 B 55 6 of 9 2.2 $ REIT - Hotel & Motel Real Estate 19.10 $ +62.3 % +67.6 % +91.0 % −3.6 % -3.2 % 88 11 3.4 % 3.2 % 1.40 24.6 1.5 0.9 8.7 3.21 15.3 4.6 % 25.3 % -3.1 % -1.8 % 1.3 % 0.99 46.0 % +1.5 % 4 0.2 % 5.5 % 2.7 131.3 % 18.7 % 3.0 (14)
ECPG Encore Capital Group Inc 08/05 +28 % 40 4/22 Stage 2 B 63 8 of 9 2.0 $ Credit Services Threatened Financial Services 94.10 $ +65.9 % +60.4 % +155.1 % −3.9 % +20.4 % 88 85 3.3 % 3.2 % 1.27 6.9 5.5 1.1 1.8 12.1 0.17 8.3 38.7 % 100.0 % 16.0 % 32.0 % 8.2 % 4.10 18.3 % +33.9 % 6 0.0 % 0.0 % 1.3 110.6 % 7.0 % 4.4 (5)
LFST Lifestance Health Group Inc 08/06 +2 % 40 4/22 Stage 2 B 73 8 of 9 4.0 $ Medical Care Facilities Threatened Healthcare 10.50 $ +34.1 % +45.8 % +163.3 % −1.2 % +14.3 % 88 98 4.1 % 3.7 % 1.12 172.0 69.9 2.6 2.6 22.2 43.4 5.5 % 32.6 % 1.6 % 1.6 % 1.4 % 0.13 68.9 % +13.9 % 6 0.0 % 0.0 % 4.9 88.6 % 5.1 % 4.5 (8)

Price Chart

Quarterly Figures

No quarterly data available.

Frequently Asked Questions

No more than 5% below the 52-week high with RS rating ≥ 70 — strength near the high.

All scanners are recalculated daily across the entire stock universe — most recently on 3. August 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).

Currently, 222 stocks pass this scanner's criteria (as of 3. August 2026). The 100 strongest hits are shown.

Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) and names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.

Related scanners

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?